Prediction of paclitaxel resistance in breast cancer: is CYP1B1*3 a new factor of influence? [electronic resource]
Producer: 20080825Description: 969-74 p. digitalISSN:- 1744-8042
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Aryl Hydrocarbon Hydroxylases
- Breast Neoplasms -- drug therapy
- Cytochrome P-450 CYP1B1
- Cytochrome P-450 Enzyme System -- genetics
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm -- genetics
- Female
- Humans
- Paclitaxel -- administration & dosage
- Polymorphism, Genetic
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.